Summary
- Current Price
- As of today, TARS price is $65.37, down -0.26% in the most recent trading session on
- Current Price All-Time High
- TARS price is currently -23.32% below its historical high of $85.25 set on
- Market Cap
- TARS current market cap is $3B, up +48.41% over the past 365 days
- PE Ratio
- TARS PE ratio is unknown
- Revenue
- TARS current annual revenue is $182.95M, up +948.62% year-over-year
- Next Earnings
- The next earnings release for TARS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Tarsus Pharmaceuticals, Inc. |
| Ticker | NASDAQ: TARS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | tarsusrx.com |
| Employees | 323 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $65.37 | |
| Price, 1D Change | -0.26% | |
| $3B | ||
| - | ||
| - | ||
| 0.59 | ||
| $183M | ||
| Revenue, 1Y Change | +948.62% | |
| -$3.07 | ||
| EPS, 1Y Change | +33.56% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.07 | ||
| EPS Estimate | -$1.40 | |
| EPS Est. Change | +54.48% | |
| $182.95M | ||
| Revenue Estimate | $444.18M | |
| Revenue Est. Change | +142.78% | |
| Current Price | $65.37 | |
| Price Target | - | $91.00 |
| Price Tgt. Change | - | +39.21% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.78 | -$4.62 | +3.25% | |
| -$3.27 | -$3.07 | +6.06% | |
| -$1.40 | N/A | +54.48% | |
| $1.37 | N/A | +144.69% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.86M | $17.45M | +76.95% | |
| $175.47M | $182.95M | +4.26% | |
| $444.18M | N/A | +142.78% | |
| $667.31M | N/A | +264.74% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $65.37 | |
| $59.46 | ||
| SMA 200 vs Price | -9.04% | |
| $73.37 | ||
| SMA 50 vs Price | +12.23% | |
| 0.59 | ||
| $3.34 | ||
| 45.00 | ||
| 46.01% | ||
| 46.92% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $182.95M | ||
| -$3.07 | ||
| $170.13M | ||
| 92.99% | ||
| -$120.57M | ||
| -65.90% | ||
| -$115.55M | ||
| -63.16% | ||
| -$106.88M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.32 | ||
| 4.43 | ||
| 4.39 | ||
| - | ||
| 2 | ||
| 9.98 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 7.58 | ||
| 8.28 | ||
| -28.66 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $224.53M | ||
| $94.82M | ||
| $377.35M | ||
| $356.71M | ||
| $152.81M | ||
| $80.61M | ||
| $72.45M | ||
| $608.00K | ||
| $27.74M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $303.52M | ||
| $290.70M | ||
| $12.83M | ||
| $237.31M | ||
| $1.23M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$83.03M | ||
| -$199.20M | ||
| $154.66M | ||
| $6.57M | ||
| -$89.59M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | ||
| Mizuho | ||
| Guggenheim | → | |
| HC Wainwright & Co. | → | |
| Goldman Sachs | → | |
| Guggenheim | → | |
| Jefferies | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Barclays | → |
Analyst sentiment
Institutional ownership
Screeners with TARS
FAQ
What is the ticker symbol for Tarsus Pharmaceuticals, Inc.?
The ticker symbol for Tarsus Pharmaceuticals, Inc. is NASDAQ:TARS
Does Tarsus Pharmaceuticals, Inc. pay dividends?
No, Tarsus Pharmaceuticals, Inc. does not pay dividends
What sector is Tarsus Pharmaceuticals, Inc. in?
Tarsus Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Tarsus Pharmaceuticals, Inc. in?
Tarsus Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Tarsus Pharmaceuticals, Inc. based in?
Tarsus Pharmaceuticals, Inc. is headquartered in United States
When did Tarsus Pharmaceuticals, Inc. go public?
Tarsus Pharmaceuticals, Inc. initial public offering (IPO) was on October 16, 2020
Is Tarsus Pharmaceuticals, Inc. in the S&P 500?
No, Tarsus Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Tarsus Pharmaceuticals, Inc. in the NASDAQ 100?
No, Tarsus Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Tarsus Pharmaceuticals, Inc. in the Dow Jones?
No, Tarsus Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Tarsus Pharmaceuticals, Inc. last earnings report?
Tarsus Pharmaceuticals, Inc.'s most recent earnings report was on November 4, 2025
When does Tarsus Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Tarsus Pharmaceuticals, Inc. is February 23, 2026
Data Sources & References
- TARS Official Website www.tarsusrx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1819790/000181979025000121/0001819790-25-000121-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1819790/000181979025000011/0001819790-25-000011-index.htm
- TARS Profile on Yahoo Finance finance.yahoo.com/quote/TARS
- TARS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tars